Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Bahrain Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: This quarter has seen the beginning of a multi-phased plan by the National Health Regulatory Authority to significantly reduce medicine prices in the country, signalling a potential advancement towards the implementation of a un...
Apr 2014 $ 1295
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Low health and pharmaceutical expenditures will continue to limit the attractiveness of the pharmaceutical market in Cambodia. Given such a profile, the country will present more commercial benefits to companies dealing with ine...
Apr 2014 $ 1295
Czech Republic Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Overall, the Czech healthcare system is facing severe challenges as it struggles to contain budget deficits. At the same time, demand for the latest pharmaceuticals and access to healthcare services is expected to continue its s...
Apr 2014 $ 1295
Denmark Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Although Denmark's pharmaceutical market is relatively small compared to other Western European countries, the demand for high quality healthcare will remain elevated by an increasing and ageing population. This demand could pro...
Apr 2014 $ 1295
Iraq Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: The projected growth of Iraq's pharmaceutical market in 2014 and 2015 is linked to an oildriven economic expansion, which is dependent on the government's ability to represent and appease the country's factions. Given the govern...
Apr 2014 $ 1295
Lithuania Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 4.4%, rising to a value of LTL2.16bn (US$751mn) in 2018. While double-digit annual growth rates are firmly in the past, som...
Apr 2014 $ 1295
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: A better-than-expected outlook for Sri Lanka's economy has led us to upwardly revise our pharmaceutical and healthcare forecasts. The government has introduced price controls on wholesale and retail prices of imported drugs, whi...
Apr 2014 $ 1295
Venezuela Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Foreign currency controls and drug price cuts will continue to affect pharmaceutical companies' profitability, with the currency devaluation and high inflation exacerbating the situation. A close relationship and effective commu...
Apr 2014 $ 1295
Morocco Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: We expect poor economic conditions in Morocco will lead to continuing decline in pharmaceutical imports and spending in the short term. However, the rate of decline in pharmaceutical sales is starting to slow, indicating that co...
Apr 2014 $ 1295
Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: We hold a very positive outlook towards growth in the Saudi Arabian medicines market over the next decade, with pharmaceutical demand underpinned by a number of factors. However, risks to our outlook are to the downside, some of...
Apr 2014 $ 1295
Serbia Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: While per capita expenditure on drugs is increasing steadily, Serbia's overall pharmaceutical market is still underdeveloped. Serbia frequently faces medicine shortages, as some retailers and pharmacists are unable to earn profi...
Apr 2014 $ 1295
Singapore Clinical Trial Market Analysis
By Kuick Research
Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers and clinicians. It also possesses one of the best healthcare infrastructure networks in th...
Apr 2014 $ 500
Ghana Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Although our USD headline forecasts for Ghana in Q2014 have been revised lower, this is largely due to currency fluctuations. We remain positive towards Ghana's healthcare and pharmaceutical markets over the long term. This is d...
Apr 2014 $ 1295
United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: UAE's increasing investment from public and private sectors in its healthcare industry is set to bring improved standards of care and increased access to medicines, as well as making it a more appealing destination for medical t...
Apr 2014 $ 1295
Vietnam Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Vietnam's reliance on imported drugs (both generic and patented) will continue to provide ample commercial opportunities for foreign drugmakers. However, the population's concerns over drug quality means that only companies with...
Apr 2014 $ 1295
Latest guidebook for Chinese Drug Recall Regulations (2014 Edition)
By Access China Management Consulting Ltd
China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained...
Mar 2014 $ 750
United Kingdom Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: The UK's health technology assessment and pricing/reimbursement decision making bodies are looking to take an increasingly hard line when determining whether a new drug provides added value to patients compared with existing the...
Mar 2014 $ 1295
Spain Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Despite the Spanish economy returning to growth in 2014, the country's pharmaceuticals and healthcare sectors show no sign of following suit. The Spanish government's ongoing cash flow troubles and aggressive fiscal austerity me...
Mar 2014 $ 1295
Slovakia Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Slovakia generally offers significant potential as a location for pharmaceutical research. This is thanks to its demographic and epidemiological profile, which is broadly similar to Western Europe; EU membership, which allows fo...
Mar 2014 $ 1295
Russia Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: A deteriorating macroeconomic picture and weakening rouble will moderate real pharmaceutical industry growth, as the consumer spending that currently underpins the pharmaceutical market loses momentum. Over the longer term, the ...
Mar 2014 $ 1295
Qatar Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Qatar is in top position among eight countries introducing new technology and practices in their healthcare systems, according to a study published at the World Innovation Summit for Health (WISH). Experts assessed the gap betwe...
Mar 2014 $ 1295
Norway Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: While Norway's reliance on pharmaceutical imports highlights opportunities for drugmakers looking to export medicines into the country, we note that the Norwegian pharmaceutical market has displayed very slow or no growth in rec...
Mar 2014 $ 1295
Moldova Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: Despite the geopolitical uncertainty rising from the Russian intervention in Kiev, we believe that Moldova's healthcare and pharmaceutical market will continue to grow in 2014 as the economy continues to improve. This is because...
Mar 2014 $ 1295
Indonesia Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: The launch of the universal healthcare system in Indonesia is generally positive for pharmaceutical firms, particularly domestic firms that commercialise generic drugs. We maintain that the rollout of the scheme will be challeng...
Mar 2014 $ 1295
Cuba Pharmaceuticals and Healthcare Report Q2 2014
By Business Monitor International
BMI View: The Cuban government continues to seek greater foreign investment to help it achieve strong economic growth, and is working hard to win the confidence of investors. Many companies in the healthcare and pharmaceutical industries ...
Mar 2014 $ 1295
Live Chat
Live Chat by Comm100